Literature DB >> 7809049

The essential light chain is required for full force production by skeletal muscle myosin.

P VanBuren1, G S Waller, D E Harris, K M Trybus, D M Warshaw, S Lowey.   

Abstract

Myosin, a molecular motor that is responsible for muscle contraction, is composed of two heavy chains each with two light chains. The crystal structure of subfragment 1 indicates that both the regulatory light chains (RLCs) and the essential light chains (ELCs) stabilize an extended alpha-helical segment of the heavy chain. It has recently been shown in a motility assay that removal of either light chain markedly reduces actin filament sliding velocity without a significant loss in actin-activated ATPase activity. Here we demonstrate by single actin filament force measurements that RLC removal has little effect on isometric force, whereas ELC removal reduces isometric force by over 50%. These data are interpreted with a simple mechanical model where subfragment 1 behaves as a torque motor whose leyer arm length is sensitive to light-chain removal. Although the effect of removing RLCs fits within the confines of this model, altered crossbridge kinetics, as reflected in a reduced unloaded duty cycle, probably contributes to the reduced velocity and force production of ELC-deficient myosins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809049      PMCID: PMC45446          DOI: 10.1073/pnas.91.26.12403

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Muscle structure and theories of contraction.

Authors:  A F HUXLEY
Journal:  Prog Biophys Biophys Chem       Date:  1957

Review 2.  Domains, motions and regulation in the myosin head.

Authors:  P Vibert; C Cohen
Journal:  J Muscle Res Cell Motil       Date:  1988-08       Impact factor: 2.698

Review 3.  The mechanism of muscular contraction.

Authors:  H E Huxley
Journal:  Science       Date:  1969-06-20       Impact factor: 47.728

4.  Proposed mechanism of force generation in striated muscle.

Authors:  A F Huxley; R M Simmons
Journal:  Nature       Date:  1971-10-22       Impact factor: 49.962

Review 5.  The mechanism of muscle contraction.

Authors:  R Cooke
Journal:  CRC Crit Rev Biochem       Date:  1986

6.  Induced changes in orientation of the cross-bridges of glycerinated insect flight muscle.

Authors:  M K Reedy; K C Holmes; R T Tregear
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

7.  Fluorescence energey transfer in myosin subfragment-1.

Authors:  D J Marsh; S Lowey
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

8.  Fluorescently labeled myosin subfragment 1: identification of the kinetic step associated with the adenosine 5'-triphosphate induced fluorescence decrease.

Authors:  D J Marsh; L A Stein; E Eisenberg; S Lowey
Journal:  Biochemistry       Date:  1982-04-13       Impact factor: 3.162

9.  Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro.

Authors:  D M Warshaw; J M Desrosiers; S S Work; K M Trybus
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

10.  Effects of partial extraction of light chain 2 on the Ca2+ sensitivities of isometric tension, stiffness, and velocity of shortening in skinned skeletal muscle fibers.

Authors:  P A Hofmann; J M Metzger; M L Greaser; R L Moss
Journal:  J Gen Physiol       Date:  1990-03       Impact factor: 4.086

View more
  48 in total

Review 1.  The structural basis of muscle contraction.

Authors:  K C Holmes; M A Geeves
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-04-29       Impact factor: 6.237

2.  The biochemical kinetics underlying actin movement generated by one and many skeletal muscle myosin molecules.

Authors:  Josh E Baker; Christine Brosseau; Peteranne B Joel; David M Warshaw
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

3.  Essential myosin light chain as a target for caspase-3 in failing myocardium.

Authors:  Alessandra Moretti; Hans-Jörg Weig; Thomas Ott; Melchior Seyfarth; Hans-Peter Holthoff; Diana Grewe; Angelika Gillitzer; Lorenz Bott-Flügel; Albert Schömig; Martin Ungerer; Karl-Ludwig Laugwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

4.  Modification of interface between regulatory and essential light chains hampers phosphorylation-dependent activation of smooth muscle myosin.

Authors:  Shaowei Ni; Feng Hong; Brian D Haldeman; Josh E Baker; Kevin C Facemyer; Christine R Cremo
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

5.  The molecular effects of skeletal muscle myosin regulatory light chain phosphorylation.

Authors:  Michael J Greenberg; Tanya R Mealy; James D Watt; Michelle Jones; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-20       Impact factor: 3.619

6.  Removal of the cardiac myosin regulatory light chain increases isometric force production.

Authors:  Kiran Pant; James Watt; Michael Greenberg; Michelle Jones; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  FASEB J       Date:  2009-05-26       Impact factor: 5.191

7.  Thiophosphorylation of myosin light chain increases rigor stiffness of rabbit smooth muscle.

Authors:  A S Khromov; A V Somlyo; A P Somlyo
Journal:  J Physiol       Date:  1998-10-15       Impact factor: 5.182

8.  Altered kinetics of contraction in skeletal muscle fibers containing a mutant myosin regulatory light chain with reduced divalent cation binding.

Authors:  G M Diffee; J R Patel; F C Reinach; M L Greaser; R L Moss
Journal:  Biophys J       Date:  1996-07       Impact factor: 4.033

9.  Functional diversity among a family of human skeletal muscle myosin motors.

Authors:  Daniel I Resnicow; John C Deacon; Hans M Warrick; James A Spudich; Leslie A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

10.  A point mutation in the regulatory light chain reduces the step size of skeletal muscle myosin.

Authors:  Jennifer J Sherwood; Guillermina S Waller; David M Warshaw; Susan Lowey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.